News & Updates

Secukinumab on par with adalimumab biosimilar in r-axSpA

19 Jun 2023 by

Treatment with secukinumab (SEC) shows no significant difference with adalimumab biosimilar (SDZ-ADL) in spinal radiographic progression, which remains low over 2 years, among patients with radiographic axial spondyloarthritis (r-axSpA), according to a phase IIIb study presented at EULAR 2023.

Secukinumab on par with adalimumab biosimilar in r-axSpA

19 Jun 2023

Cutaneous eruptions from ibrutinib overlap with EGFR-induced adverse events

19 Jun 2023

Several cutaneous toxicities arising from ibrutinib therapy are similar to those caused by the use of selective epidermal growth factor receptor (EGFR) inhibitors, except for petechiae, according to a study.

Cutaneous eruptions from ibrutinib overlap with EGFR-induced adverse events

19 Jun 2023

Updated CodeBreak 200 analyses boost sotorasib role in KRASG12C-mutant NSCLC

19 Jun 2023 by

In the PRO analyses of the phase III CodeBreak 200 trial, the first-in-class KRAS^G12C inhibitor sotorasib improved quality of life (QoL) of patients with pretreated KRAS^G12C-mutated advanced non-small-cell lung cancer (NSCLC) compared with docetaxel.

Updated CodeBreak 200 analyses boost sotorasib role in KRASG12C-mutant NSCLC

19 Jun 2023

Maternal OCD tied to adverse pregnancy, delivery, neonatal outcomes

19 Jun 2023

Pregnant women with obsessive–compulsive disorder (OCD) are at higher risk of adverse pregnancy, delivery, and neonatal outcomes, including gestational diabetes, pre-eclampsia, caesarean delivery, preterm birth, neonatal respiratory distress, neonatal infections, and major congenital malformations, among others, as reported in a study.

Maternal OCD tied to adverse pregnancy, delivery, neonatal outcomes

19 Jun 2023

Early hysterectomy poses increased CVD risk

18 Jun 2023

Undergoing early hysterectomy appears to put women at heightened risk of a composite of cardiovascular disease (CVD), especially stroke, as reported in a study.

Early hysterectomy poses increased CVD risk

18 Jun 2023

What are the barriers to communication between pharmacists during transitions of care?

18 Jun 2023

Several barriers to communication exist between pharmacists during transitions of care (TOC) across healthcare settings, reports a US study.

What are the barriers to communication between pharmacists during transitions of care?

18 Jun 2023

Colon cancer survival with neoadjuvant chemo vs upfront surgery a toss-up

18 Jun 2023

In the treatment of patients with colon cancer, neoadjuvant chemotherapy does not appear to yield better survival benefit than standard upfront surgery, according to the results of the phase III NeoCol trial presented at ASCO 2023.

Colon cancer survival with neoadjuvant chemo vs upfront surgery a toss-up

18 Jun 2023

Low-dose atropine helps control childhood myopia progression

18 Jun 2023

The novel, preservative-free, low-dose atropine formulation NVK002 appears to be beneficial in the treatment of myopia progression in children when compared with placebo, according to the results of a phase III study.

Low-dose atropine helps control childhood myopia progression

18 Jun 2023

Triglyceride-glucose index predicts hypertension in Singaporeans

17 Jun 2023 by

Singaporeans with higher triglyceride-glucose index are at higher risk of developing hypertension, as reported in a study.

Triglyceride-glucose index predicts hypertension in Singaporeans

17 Jun 2023

Is ursodeoxycholic acid beneficial in critically ill patients with sepsis?

17 Jun 2023

Critically ill patients with sepsis or septic shock who use ursodeoxycholic acid (UDCA) do not seem to experience improvement in shock severity and resolution, reveals a recent study. However, they have a higher chance of being extubated and not needing mechanical ventilation (MV) on the third day of admission to the intensive care unit (ICU).

Is ursodeoxycholic acid beneficial in critically ill patients with sepsis?

17 Jun 2023

News & Updates

Filter by Specialty:

Specialty:

Secukinumab on par with adalimumab biosimilar in r-axSpA

Secukinumab on par with adalimumab biosimilar in r-axSpA

Cutaneous eruptions from ibrutinib overlap with EGFR-induced adverse events

Cutaneous eruptions from ibrutinib overlap with EGFR-induced adverse events

Updated CodeBreak 200 analyses boost sotorasib role in KRASG12C-mutant NSCLC

Updated CodeBreak 200 analyses boost sotorasib role in KRASG12C-mutant NSCLC

Maternal OCD tied to adverse pregnancy, delivery, neonatal outcomes

Maternal OCD tied to adverse pregnancy, delivery, neonatal outcomes

Early hysterectomy poses increased CVD risk

Early hysterectomy poses increased CVD risk

What are the barriers to communication between pharmacists during transitions of care?

What are the barriers to communication between pharmacists during transitions of care?

Colon cancer survival with neoadjuvant chemo vs upfront surgery a toss-up

Colon cancer survival with neoadjuvant chemo vs upfront surgery a toss-up

Low-dose atropine helps control childhood myopia progression

Low-dose atropine helps control childhood myopia progression

Triglyceride-glucose index predicts hypertension in Singaporeans

Triglyceride-glucose index predicts hypertension in Singaporeans

Is ursodeoxycholic acid beneficial in critically ill patients with sepsis?

Is ursodeoxycholic acid beneficial in critically ill patients with sepsis?